Howard Rossman

Statistics

Publications

Citations

673

H-Index

Active since

2004

Affiliations

Michigan Institute for Neurological Disorders(Current)

Biogen (United States)

Howard Rossman is an author at Michigan Institute for Neurological Disorders specializing in multiple sclerosis, multiple sclerosis pharmacotherapy, and relapsing-remitting multiple sclerosis treatment.

Publications per year

2004–2019

Publications

Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial

Diego Cadavid, Michelle Mellion, Raymond Hupperts et al. · The Lancet Neurology · 2019 · 185 citations

Life Sciences, Immunology, Neurology +11

GLANCE

Andrew Goodman, Howard Rossman, Amit Bar‐Or et al. · Neurology · 2009 · 129 citations · Full text

Computing, Computer Science, Data Science +12

Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage

Massimo Filippi, Maria A. Rocca, Elisabetta Pagani et al. · Journal of Neurology Neurosurgery & Psychiatry · 2013 · 113 citations

Life Sciences, Neurology, Neuroscience +17

Characterizing absolute lymphocyte count profiles in dimethyl fumarate–treated patients with MS

Robert J. Fox, Andrew Chan, Ralf Gold et al. · Neurology Clinical Practice · 2016 · 104 citations · Full text

Life Sciences, Immunology, Pharmacology +14

Natalizumab treatment shows no clinically meaningful effects on immunization responses in patients with relapsing-remitting multiple sclerosis

Michael D. Kaufman, Gabriel Pardo, Howard Rossman et al. · Journal of the Neurological Sciences · 2014 · 82 citations

Life Sciences, Immunology, Neurology +12

1–5 of 8